Cipro and Doxy

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

PROGRAM SUPPORT CENTER ACQ MGMT SVC

Contract Value

Not provided

Codes & Classification
Solicitation Number

CandD

NAICS

-

Classification Code

6505

Additional Details
Set Aside

SBA

Place of Performance

Perry Point, Maryland, UNITED STATES

SourceSAM
The Department of Health and Human Services (DHHS), through its Supply Service Center (SSC) located in Perry Point, Maryland, is conducting a sources sought inquiry to identify potential suppliers for two critical pharmaceutical products: Isoniazid 300mg tablets (packaged in bottles of 30, with a total quantity of 7,500 bottles) and Rifampin 300mg capsules (packaged in bottles of 60, with a total quantity of 7,500 bottles). The primary requirement for both products is that they be supplied with the longest possible dating, ensuring maximum shelf life and utility for the government’s inventory. This procurement activity is classified under Product Service Code 6505, which pertains to drugs and biologicals. The intended outcome is to secure a reliable supply of these medications, which are essential for public health initiatives, particularly in the treatment and management of infectious diseases such as tuberculosis. The focus on extended dating underscores the government’s need for products that will remain viable for as long as possible, minimizing waste and ensuring readiness for future distribution or emergency response. The opportunity is set aside for Small Business Administration (SBA) eligible entities, reflecting the government’s commitment to supporting small business participation in federal contracting. Interested parties should ensure they meet the relevant SBA criteria to be considered for this opportunity. The contracting entity overseeing this procurement is the Program Support Center Acquisition Management Service, a federal office within the Office of the Assistant Secretary for Administration (ASA) at DHHS. The place of performance for this requirement is Perry Point, Maryland, United States. Potential suppliers are encouraged to review their capabilities in relation to the specified pharmaceutical products, paying particular attention to their ability to provide the required quantities with the longest possible expiration dating. No additional documentation or attachments are provided with this notice. For further information or to express interest, contractors should contact the primary point of contact, Tim Bouchelle, via email at [email protected] or by phone at 443-947-6039. The notice was originally posted on July 4, 2026, with a response deadline of April 27, 2026. Although the notice is currently marked as inactive, the details provided herein remain relevant for understanding the scope and requirements of similar future opportunities. Contractors evaluating this opportunity should consider their production capacity, supply chain reliability, and compliance with federal pharmaceutical standards to determine alignment with the government’s needs.